期刊文献+

绝经后妇女雌激素替代疗法对血脂的影响 被引量:4

Lipid Metabolic Changes Induced by Hormone Replacement Therapy
下载PDF
导出
摘要 目的探讨雌激素对绝经后妇女脂代谢的影响。 方法 2 5例绝经后妇女 ,其中 15例为口服结合雌激素组 (研究组 ) ,10例为不用药组 (对照组 ) ,观察血浆总胆固醇 (TC)、甘油三脂 (TG)、高密度脂蛋白 -胆固醇 (HDL-C)、低密度脂蛋白 -胆固醇 (LDL -C)和α -脂蛋白 (α -Lp)及TC/HDL -C、LDL -C/HDL -C比值的变化 ;观察研究组血清FSH、LH、E2 和E1的变化。 结果激素替代疗法 (HRT)后 ,HDL -C随用药时间的延长上升 ,TC/HDL-C及LDL -C/HDL -C比值明显降低 ,α-LP下降 ,尤其在第 6个月后。研究组血清FSH和LH 3个月后即显著下降 ,而E2 和E1明显升高 (P <0 .0 1)。 结论绝经后妇女使用雌激素 0 .6 2 5mg/d ,合并安宫黄体酮 4mg/d对升高HDL -C ,降低TC/HDL -C、LDL -C/HDL -C比值与α-LP的下降起着有益的作用 ,从而对绝经后妇女冠心病的发生起到预防作用。 s: Objective To investigate the effect of hormone replacement therapy on plasma lipid and lipoprotein metabolism. Methods 25 healthy postmenopausal women were studied. 15 women were given conjugated estrogen (CE) 0.625mg/d and medroxyprogesterone acetate (MPA) 4mg/d for 12 months (HRT group) while 10 cases didn't receive any hormonal medication (control group). The plasma levels of total cholesterol (TC), triglyceride(TG), high-density lipoprotein cholesterol(HDL-C), low-density lipoprotein-cholesterol(LDL-C) and α-lipoprotein (α-Lp) were evaluated at 0,3,6,and 12month, respectively, and plasma FSH, LH, E 2, and E 1 levels were measured at the same point in both groups. Results In HRT group TC and TG levels were slightly increased, but no significant difference was detected. HDL-C was significantly increased in HRT group while TC/HDL-C and LDL-C/HDL-C ratios were significantly dereased. FSH and LH levels were lowered, howerver E 2 and E 1 levels were elevated at 3 month (P<0.01). Conclusion Hormone replacement therapy has a potential protective effect on decreasing the morbidity of coronary heart disease in postmenopausal women by increasing plasma HDL-C level and decreasing TC/HDL-C and LDL-C/HDL-C ratios
出处 《上海第二医科大学学报》 CSCD 2000年第6期544-546,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 绝经 雌激素替代疗法 血脂 postmenopause hormone replacement therapy plasma lipid
  • 相关文献

参考文献3

二级参考文献15

  • 1王抒,李健斋,赵淑华,唐蔚青,褚德发,李培瑛,满咏,李红霞.血清载脂蛋白参考值[J].中华医学检验杂志,1996,19(6):343-348. 被引量:30
  • 2吕文佩 郑淑蓉 杨欣.激素替代治疗对更年期症状的治疗作用[J].中华妇产科杂志,1997,32(10):563-563. 被引量:9
  • 3朱建民,临床心血管病杂志,1992年,8卷,166页 被引量:1
  • 4汪俊军,中华医学检验杂志,1991年,14卷,198页 被引量:1
  • 5张为远,中华医学检验杂志,1991年,14卷,316页 被引量:1
  • 6刘棣临,实用妇产医学手册,1991年 被引量:1
  • 7赵晓晖,中华妇产科杂志,1989年,24卷,357页 被引量:1
  • 8白文佩,中华妇产科杂志,1997年,32卷,563页 被引量:1
  • 9陶寿琪,中华心血管病杂志,1997年,25卷,234页 被引量:1
  • 10中华心血管病杂志编委会血脂异常防治对策专,中华心血管病杂志,1997年,25卷,169页 被引量:1

共引文献35

同被引文献28

  • 1张清学,邝健全.绝经后妇女应用激素治疗的利弊[J].新医学,2005,36(8):491-492. 被引量:3
  • 2张蓉,刘宇,刘秉文.血浆脂蛋白脂酶及肝脂酶的比色测定法[J].华西医科大学学报,1996,27(1):106-110. 被引量:34
  • 3[4]Su S,Hsiao CG,Chu C,et al.Effects of pravastatin on leftventricular mass in patients with hyperlipidemia and essential hypertension[J]. Am J Cardiol, 2000, 86(5):514~518. 被引量:1
  • 4[5]Hokanson JE,Austin MA.Plasma trylyceride level is a risk factor for cardiovascular disease independent of high density lipoprotein cholelaterol level;ametaamslysis of population-dased prospective studies[J]. J Cardiovasc Risk, 1996, 3: 231. 被引量:1
  • 5Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholelaterol level;a meta-analysis of population-based prospective studies. J Cardiovasc Risk,1996,3(2):213-219. 被引量:1
  • 6雷冬竹 贺平 杨帆.非绝经妇女子宫切除后尼尔雌激素替代治疗的临床观察[J].华南大学学报:医学版,2001,29(6):584-584. 被引量:1
  • 7Henderson BE, Ross RK, Lobo RA, et al. Re-evaluating the role of progestogen therapy after the menopause[J]. Fertil Steril, 1988,49 (5 Suppl 2) :9s-15s. 被引量:1
  • 8Nabulsi AA, Folsom AR, White A, et al. Association of hormonereplacement therapy with various cardiovascular risk factors in postmenopausal women [J]. N Engl J Med, 1993,328:1069-1075. 被引量:1
  • 9Fahraeus L, Sydsjo A, WaUentin L, et al. Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate[J]. Fertil Steril, 1986,45:503-506. 被引量:1
  • 10Luciano AA, De Souza MJ, Roy MP, et al. Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A doubleblind, prospective study of sequential versus continuous therapy [J].J Reprod Med, 1993, 38:207-214. 被引量:1

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部